Prestige Brand Holdings has voluntarily recalled 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops across the United States because the company cannot confirm that the products are sterile, according to an enforcement report from the Food and Drug Administration.
The recall covers 15-milliliter bottles marked with lot code 2552A and an expiration date of September 30, 2027. The products were distributed by Medtech Products Inc., which operates under Prestige Consumer Healthcare. Consumers can use the lot number and expiration date to determine whether bottles in their possession are included in the recall.
The FDA designated the action as a Class II recall. Under the agency’s classification system, this category applies when use of or exposure to a product may result in temporary or medically reversible health effects, while the likelihood of serious health consequences is considered remote. The report cited a lack of assurance of sterility, indicating that the drops may not meet required standards intended to prevent contamination.
The recall is part of broader regulatory attention involving eye-care products. Other eye drop recalls have recently involved sterility or contamination concerns, including products sold under separate brands and by different companies. Each recall applies to specific products, lots and distribution arrangements.
Prestige Consumer Healthcare also owns consumer health brands including Dramamine, Luden’s and Anacin. In June 2026, the company completed its approximately $1.05 billion acquisition of the Breathe Right brand and other assets from Foundation Consumer Healthcare.
At the time of publication on August 21, 2026, no company response was included. The available report did not identify confirmed injuries or illnesses associated with the recalled Clear Eyes product. Consumers with affected bottles should review official recall information and seek guidance from a pharmacist, physician or the manufacturer if they have questions about use, disposal or possible symptoms.